| Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet) (NCT05818449) | University of Cologne | 2022-06-01 |
| Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC (NCT05055167) | The First Affiliated Hospital of Xiamen University | 2021-08-30 |
| A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer (NCT04432207) | Imugene Limited | 2020-11-30 |
| Immunotherapy in Patient With Poor General Condition (NCT04108026) | Intergroupe Francophone de Cancerologie Thoracique | 2020-10-14 |
| Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC (NCT04238169) | Xinqiao Hospital of Chongqing | 2020-09-01 |
| Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) (NCT03532698) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2020-08-01 |
| Tumor Mutational Burden in Lung Cancer Patients (NCT04289259) | Assistance Publique - Hôpitaux de Paris | 2020-06-10 |
| Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis (NCT03526900) | Spanish Lung Cancer Group | 2018-07-07 |
| Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition (NCT03275597) | University of Wisconsin, Madison | 2018-02-20 |
| Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC (NCT03543683) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2018-01-01 |
| A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer (NCT02450539) | Eli Lilly and Company | 2015-08-06 |
| Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer (NCT01999673) | Peregrine Pharmaceuticals | 2013-12-01 |
| Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC (NCT02047344) | Golden Biotechnology Corporation | 2013-10-01 |
| A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC (NCT01798485) | Synta Pharmaceuticals Corp. | 2013-04-01 |
| Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial (NCT02176369) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-02-01 |
| SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer (NCT01086254) | Sanofi | 2010-05-01 |
| Phase II Avastin Trial for Stage IIIB/IV NSCLC (NCT00766246) | Pharmatech | 2008-10-01 |